Tilray Brands Inc (TLRY)

[Deetew]

https://www.forbes.com/sites/emilyearlenbaugh/2020/07/06/cannabis-may-reduce-deadly-covid-19-lung-inflammation-researchers-explain-why/?fbclid=IwAR12jMManyHmurTZ2fj_j050chOkNlE1PWvokBN6BWHU1jJfgSLO1W8AQGQ#b2cb9264d9d1

The authors also note that CBD isn’t the only cannabinoid that shows promise as an anti-inflammatory medicine. THC has also shown powerful anti-inflammatory results, but it’s less well tolerated than CBD, with common symptoms like disorientation, anxiety, and increased heart rate. Research on CBD, on the other hand, shows it to be safe and well-tolerated with dosing as high as 1500 mg a day, for a period of up to two weeks. The authors explain that this “suggests its feasibility to reduce SARS-CoV2 induced lung inflammation/ pathology and disease severity.”